Venture Into High-Volatility Corners of the Market With These 3 ETFs

The article argues that high-risk, high-reward segments—specifically clinical-stage biotech, micro-cap stocks, and junior gold mining companies—may become more accessible as investors use targeted ETFs to help manage risk. It frames the idea as improving portfolio “approachability” rather than citing any specific earnings, policy, or macro catalyst.